Guo Yue-Xin, Wang Bo-Ya, Gao Han, Hua Rong-Xuan, Gao Lei, He Cheng-Wei, Wang Ying, Xu Jing-Dong
Department of Oral Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Eight Program of Clinical Medicine, Peking University Health Science Center, Beijing, China.
Front Mol Biosci. 2022 Apr 26;9:864039. doi: 10.3389/fmolb.2022.864039. eCollection 2022.
Peroxisome proliferator-activated receptor (PPAR)-α is a ligand-activated transcription factor distributed in various tissues and cells. It regulates lipid metabolism and plays vital roles in the pathology of the cardiovascular system. However, its roles in the gastrointestinal tract (GIT) are relatively less known. In this review, after summarizing the expression profile of PPAR-α in the GIT, we analyzed its functions in the GIT, including physiological control of the lipid metabolism and pathologic mediation in the progress of inflammation. The mechanism of this regulation could be achieved <i>via</i> interactions with gut microbes and further impact the maintenance of body circadian rhythms and the secretion of nitric oxide. These are also targets of PPAR-α and are well-described in this review. In addition, we also highlighted the potential use of PPAR-α in treating GIT diseases and the inadequacy of clinical trials in this field.
过氧化物酶体增殖物激活受体(PPAR)-α是一种配体激活的转录因子,分布于各种组织和细胞中。它调节脂质代谢,在心血管系统病理学中发挥重要作用。然而,其在胃肠道(GIT)中的作用相对鲜为人知。在本综述中,在总结PPAR-α在胃肠道中的表达谱后,我们分析了其在胃肠道中的功能,包括脂质代谢的生理控制以及炎症进展中的病理介导作用。这种调节机制可通过与肠道微生物的相互作用实现,并进一步影响身体昼夜节律的维持和一氧化氮的分泌。这些也是PPAR-α的靶点,本综述对此进行了详细描述。此外,我们还强调了PPAR-α在治疗胃肠道疾病中的潜在用途以及该领域临床试验的不足之处。